1-Year Clinical Outcomes of ASD Closure following Transseptal Mitral Valve-in-Valve Procedures Using SAPIEN 3 Valve Prosthesis in a Propensity-Matched Analysis
We Recommend
Disclosures
Within the past 12 months, I or my spouse/partner have had a financial interest/arrangement or affiliation with the organization(s) listed below:
- Consultant Fee/Honoraria/Speaker's Bureau (Both) - Edwards Lifesciences; LivaNova (Caisson Valve); Abbott Vascular; Boston Scientific Corporation; NeoChord